Asset Details
Do you wish to reserve the book?
Clinical predictive fusion network for accurate disease prediction in patient cohorts
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Clinical predictive fusion network for accurate disease prediction in patient cohorts
Do you wish to request the book?
Clinical predictive fusion network for accurate disease prediction in patient cohorts
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Clinical predictive fusion network for accurate disease prediction in patient cohorts
2025
Overview
The increasing complexity of healthcare data demands predictive models that are both accurate and interpretable. This study presents the Clinical Predictive Fusion Network (CPFN). This adaptive ensemble learning framework integrates Logistic Regression, Random Forest, and Support Vector Machine classifiers through a validation-driven weighted fusion strategy. The model’s adaptive weighting enables it to learn the relative reliability of base classifiers across multimodal patient datasets. CPFN was evaluated using 10-fold stratified cross-validation on disease-specific (cardiology, neurology, diabetes, pulmonology, and oncology) and a synthetically fused multi-disease dataset, achieving up to 93.0 ± 0.4% accuracy on individual datasets and 95.5 ± 0.3% on the combined dataset. Other metrics included a recall of 92.0 ± 0.5%, F1-score of 92.5 ± 0.4%, and ROC-AUC ranging from 0.95 to 0.975 (95% CI, bootstrap 1000 resamples). These results demonstrate that CPFN maintains consistent and generalizable performance across heterogeneous data sources. The model’s transparent fusion design and detailed pseudocode enhance reproducibility and clinical applicability, positioning CPFN as a scalable, data-driven decision-support framework for next-generation predictive healthcare systems.
